Beating rhythmically and suspended in a jar, tiny heart-like structures made from stem cells are the latest innovation for drug testing — technology that has the potential to save pharmaceutical companies money. They're developed by Canadian-backed biotech firm Novoheart Ltd., which hopes to revolutionize how drugs make it to market.
Continue reading...
No comments:
Post a Comment